Associate Professor, Radiation Oncology, Stanford University Medical Center
Radiation Oncology
Dr. Albert Koong, MD
|
|
Give Review
Albert Koong, MD practices Radiation Oncology. He graduated from Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine is ranked 19 in research and 29 in primary care medicine He has 2 awards "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Albert Koong is also published. He has 77 publications published. The lastest publication: "Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer.' Albert Koong accepts all Medicare patients.
Publications
- Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer.
- Predictors of Toxicity Associated With Stereotactic Body Radiation Therapy to the Central Hepatobiliary Tract.
- Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma.
- Ire1 Has Distinct Catalytic Mechanisms for XBP1/HAC1 Splicing and RIDD.
- Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity.
- Galectin-1 Mediates Radiation-Related Lymphopenia and Attenuates NSCLC Radiation Response.
- Stereotactic body radiation therapy in pancreatic cancer: the new frontier.
- Baseline Metabolic Tumor Volume and Total Lesion Glycolysis Are Associated With Survival Outcomes in Patients With Locally Advanced Pancreatic Cancer Receiving Stereot...
- High Serum Levels of Vascular Endothelial Growth Factor-A and Transforming Growth Factor-β1 Before Neoadjuvant Chemoradiotherapy Predict Poor Outcomes in Patients with...
- Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: exp...
- Cone beam CT imaging with limited angle of projections and prior knowledge for volumetric verification of non-coplanar beam radiation therapy: a proof of concept study.
- Clinical Implementation of Intrafraction Cone Beam Computed Tomography Imaging During Lung Tumor Stereotactic Ablative Radiation Therapy.
- Impact of Chemotherapy on Normal Tissue Complication Probability Models of Acute Hematologic Toxicity in Patients Receiving Pelvic Intensity Modulated Radiation Therapy.
- Safety of (90)y radioembolization in patients who have undergone previous external beam radiation therapy.
- Chemoradiotherapy Before and After Surgery for Locally Advanced Esophageal Cancer: A SEER-Medicare Analysis.
- Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement?
- First study of on-treatment volumetric imaging during respiratory gated VMAT.
- Identification and Characterization of a Potent Activator of p53-Independent Cellular Senescence via a Small-Molecule Screen for Modifiers of the Integrated Stress Res...
- Metabolic Tumor Volume Predicts Disease Progression and Survival in Patients with Squamous Cell Carcinoma of the Anal Canal.
- Dosimetric Analysis of Organs at Risk During Expiratory Gating in Stereotactic Body Radiation Therapy for Pancreatic Cancer.
- Intrafraction Verification of Gated RapidArc by Using Beam-Level Kilovoltage X-Ray Images.
- Antiangiogenic and radiation therapy: early effects on in vivo computed tomography perfusion parameters in human colon cancer xenografts in mice.
- Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma.
- A Novel Aldehyde Dehydrogenase-3 Activator Leads to Adult Salivary Stem Cell Enrichment In Vivo.
- Quantitation of Human Papillomavirus DNA in Plasma of Oropharyngeal Carcinoma Patients.
- Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer.
- Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer.
- Tumor galectin-1 mediates lung cancer growth and metastasis through regulation of T-cell apoptosis.
- Unfolded protein response regulation in keloid cells.
- Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis.
- Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
- Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal.
- Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma.
- A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer.
- Expression of p16(INK4A) but not hypoxia markers or poly adenosine diphosphate-ribose polymerase is associated with improved survival in patients with pancreatic adeno...
- Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies.
- Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer.
- 18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy.
- Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer.
- Interfractional uncertainty in the treatment of pancreatic cancer with radiation.
- Imaging the unfolded protein response in primary tumors reveals microenvironments with metabolic variations that predict tumor growth.
- The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathways.
- Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
- Pancreatic tumor motion on a single planning 4D-CT does not correlate with intrafraction tumor motion during treatment.
- A primer on image-guided radiation therapy for the interventional radiologist.
- Detection of solitary humeral metastasis from pancreatic adenocarcinoma with F-18 FDG PET/CT.
- X box-binding protein 1 regulates angiogenesis in human pancreatic adenocarcinomas.
- Safety and efficacy of percutaneous fiducial marker implantation for image-guided radiation therapy.
- Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas.
- Preferential cytotoxicity of bortezomib toward hypoxic tumor cells via overactivation of endoplasmic reticulum stress pathways.
- Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer.
- High-dose single-fraction radiotherapy: exploiting a new biology?
- Molecular imaging of hypoxia-inducible factor 1 alpha and von Hippel-Lindau interaction in mice.
- Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer.
- Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas.
- Multiplexed protein detection by proximity ligation for cancer biomarker validation.
- Impact of integrated PET/CT on variability of target volume delineation in rectal cancer.
- Hypoxia and the unfolded protein response.
- Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization.
- Plasma osteopontin is an independent prognostic marker for head and neck cancers.
- Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors.
- Targeting XBP-1 as a novel anti-cancer strategy.
- An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers.
- Galectin-1: a link between tumor hypoxia and tumor immune privilege.
- Identification of mitogen-activated protein kinase signaling pathways that confer resistance to endoplasmic reticulum stress in Saccharomyces cerevisiae.
- The unfolded protein response: a novel component of the hypoxic stress response in tumors.
- Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancr...
- A noninvasive approach for assessing tumor hypoxia in xenografts: developing a urinary marker for hypoxia.
- Identification of hypoxia-regulated proteins in head and neck cancer by proteomic and tissue array profiling.
- XBP1 is essential for survival under hypoxic conditions and is required for tumor growth.
- The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers.
- Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer.
- Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas.
- Estimating DNA repair by sequential evaluation of head and neck tumor radiation sensitivity using the comet assay.
- Lumbosacral spine and marrow cavity modeling of acute hematologic toxicity in patients treated with intensity modulated radiation therapy for squamous cell carcinoma o...
- False positive 18F-fluorodeoxyglucose positron emission tomography/computed tomography liver lesion mimicking metastasis in 2 patients with gastroesophageal cancer.
Schools
Northwestern Center Feinberg School of Medicine
Kaiser Permanente Med Grp
Stanford University Hospital
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
Stanford University -
Kaiser Permanente Medical Group -
Northwestern University Feinberg School of Medicine
Hospital
-
Stanford Health Care -
Lucile Packard Children's Hospital Stanford
Drug Facts
| NPI NUMBER | 1598803512 | |
| NPPES Provider LastName | KOONG | |
| NPPES Provider FirstName | ALBERT | |
| NPPES Provider ZIPCode | 94305 | |
| NPPES Provider State | CA | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 16.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1598803512 |
| Last Name Of The Provider | KOONG |
| First Name Of The Provider | ALBERT |
| View All |
Similar Doctors
|
|
Dr. Christopher R. King, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stanley E. Chism, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel S. Kapp, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sandra H. Birdwell, MD |
|
|
Dr. Scott V. Bratman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carolina E. Fasola, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sara A. Dudley, MD |
|
|
Dr. Michael A. Garcia, MD |
|
|
Dr. Chuong Nguyen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adam M. Schmitt, MD |